COMMUNIQUÉS West-GlobeNewswire

Marrone Bio Innovations Announces Zequanox® Distribution Partnership

15/03/2018 - 13:31

DAVIS, Calif., March 15, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental [...]

Sport Endurance Wholly-Owned Subsidiary, Yield Endurance, Enters into Note Purchase Agreement for Gross Proceeds of $5 Million in Bitcoin

15/03/2018 - 13:31

JERSEY CITY, N.J., March 15, 2018 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTCQB:SENZ) (the “Company”) and its wholly-owned subsidiary, Yield Endurance, Inc., today announced entering into a note purchase agreement [...]

Innovation Pharmaceuticals Views Brilacidin-OM as Clearly Differentiated Compared to Limited Competition for Preventing Severe Oral Mucositis

15/03/2018 - 13:30

BEVERLY, Mass., March 15, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to provide shareholders with a status report on the [...]

Agritek Holdings, Inc. Announces Plans For Purchase Of New 15,000 Sq. ft. Cultivation And Manufacturing Facility In San Juan, Puerto Rico With Partner 1919 Clinic

15/03/2018 - 13:30

LOS ANGELES, CA, March 15, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]

Minerva Neurosciences to Host Key Opinion Leader Meeting on the Negative Symptoms of Schizophrenia on Thursday, March 22

15/03/2018 - 13:30

WALTHAM, Mass., March 15, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV ), a biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today [...]

BioCorRx Provides Update on New Weight Management Program

15/03/2018 - 13:08

ANAHEIM, CA, March 15, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced an update on [...]

Organovo to Present at H.C. Wainwright Nash Investor Conference

15/03/2018 - 13:05

SAN DIEGO, March 15, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today announced that Chief Executive Officer Taylor J. Crouch is scheduled to speak at the H.C. Wainwright NASH Investor [...]

Midatech announces changes in Senior Management Team

15/03/2018 - 13:01

15 March 2018 Midatech Pharma PLC ("Midatech" or the "Company") Midatech announces changes in Senior Management Team Midatech (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on [...]

Endocyte Nominates Dawn Svoronos for Election to Its Board of Directors and Announces Other Board Developments

15/03/2018 - 13:01

WEST LAFAYETTE, Ind., March 15, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced the nomination of [...]

Verona Pharma to Present at Upcoming Healthcare Investor Conferences

15/03/2018 - 13:00

LONDON, March 15, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

Matinas BioPharma to Present at the Oppenheimer 28th Annual Healthcare Conference

15/03/2018 - 13:00

BEDMINSTER, N.J., March 15, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, [...]

Caladrius Biosciences to Host Fourth Quarter and Year End 2017 Financial Results Conference Call on Thursday, March 22, 2018 at 4:30 p.m. Eastern Time

15/03/2018 - 13:00

BASKING RIDGE, N.J., March 15, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]

IBEX Reports Results for the Second Quarter and the Six Months Ended January 31, 2018

15/03/2018 - 13:00

MONTREAL, March 15, 2018 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture:IBT) today reported its financial results for the six months ended January 31, 2018. “As anticipated, the [...]

Onconova Therapeutics to Present Data on a First-in-class Dual Inhibitor of CDK4/6 + ARK5 at the American Association for Cancer Research Annual Meeting 2018

15/03/2018 - 13:00

NEWTOWN, Pa., March 15, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a [...]

BeyondSpring Chief Medical Officer Presents at Three Prominent Industry Conferences in March 2018

15/03/2018 - 13:00

NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical-stage biopharmaceutical company focused on the development of transforming immuno-oncology cancer therapies, today [...]

Cellectar Announces Late-Breaking Poster Presentations at AACR 2018 Featuring PDCs and CLR 131

15/03/2018 - 13:00

MADISON, Wis., March 15, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]

Selecta Biosciences Announces Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update

15/03/2018 - 13:00

SEL-212 Severe Gout Program on Track; Additional Phase 2 Data for Higher Dose Cohorts to be Presented on April 9 th or 10 th , 2018 at PANLAR Congress Phase 1 Clinical Trial of SEL-403 for Mesothelioma Initiated Company [...]

New Data on Molecular Templates’ Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Annual Meeting 2018

15/03/2018 - 13:00

Presentations will feature data on 1) the company’s Antigen Seeding Technology (AST) platform, and 2) MT-5111, an Engineered Toxin Body with a novel MOA against HER2 positive cancers AUSTIN, Texas, March 15, 2018 (GLOBE [...]

Extendicare Announces March 2018 Dividend of C$0.04 per Share

15/03/2018 - 13:00

MARKHAM, Ontario, March 15, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]